Work

Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder

Year: 2018

Type: article

Study design: Clinical Trial

Source: Psychopharmacology

DOI: 10.1007/s00213-018-4986-5

Authors: Jennifer R. Schroeder, Karran A. Phillips, David H. Epstein, Michelle L. Jobes, Melody A. Furnari, Ashley P. Kennedy, Markus Heilig, Kenzie L. Preston

Institutions: Johns Hopkins University, Johns Hopkins Bayview Medical Center, National Institutes of Health, National Institute on Drug Abuse, Linköping University

Language: English

Topic: Opioid Use Disorder Treatment

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Vetenskapsrådet, National Institutes of Health, National Institute on Drug Abuse

Awards: G7844849508, New approaches to addiction treatment

OpenAlex ID: W2886925611

FWCI: 2.875

Cites: 27

Cited by: 19

Related to: 10